Lowering Drug Costs for American Families Act
Key claim: The Lowering Drug Costs for American Families Act (HR6166, 119th Congress) was referred to the House Energy and Commerce, Ways and Means, and Education and Workforce committees to advance measures lowering prescription drug costs.
Abstract
(HR6166 · 119th Congress) Latest action (2025-11-20): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
HR6166 is another introduced vehicle in the 119th Congress aimed at lowering prescription drug costs, joining a crowded field of pricing bills spanning Medicare negotiation, PBM oversight, and copay caps. Its tri-committee referral (Energy and Commerce, Ways and Means, Education and Workforce) signals intent to touch Medicare, Medicaid, and ERISA-regulated employer plans, though no operative mechanism is public at introduction.